Healthcare Stocks Rally on Budget Boost Amid Market Slump

HEALTHCAREBIOTECH
Whalesbook Logo
AuthorVihaan Mehta|Published at:
Healthcare Stocks Rally on Budget Boost Amid Market Slump
Overview

Despite a market-wide downturn triggered by increased Securities Transaction Tax (STT) on futures and options, leading hospital chains like Max Healthcare Institute and Aster DM Healthcare saw significant gains on February 1, 2026. The Union Budget 2026-27 announced a substantial ₹1.05 trillion allocation for the healthcare sector and unveiled plans for five medical tourism hubs, alongside initiatives to train 1.5 lakh caregivers and expand allied health professional institutions. While Narayana Hrudayalaya also posted gains, Apollo Hospitals Enterprises saw its intraday gains erased by the market's close.

THE SEAMLESS LINK
The robust performance of healthcare stocks presented a stark contrast to the broader market's decline, underscoring the sector's perceived resilience and the significant positive impact of the Union Budget 2026-27's fiscal proposals. While the Nifty 50 and Sensex registered losses exceeding 2.2 percent due to the increased STT on derivatives, hospital operators experienced a surge driven by targeted government support and strategic growth opportunities.

Budgetary Tailwinds Propel Healthcare

The healthcare sector received a considerable boost with an allocation of ₹1.05 trillion for fiscal year 2027. This financial commitment is complemented by a strategic vision to establish five regional medical tourism hubs in partnership with the private sector. Analysts anticipate these hubs will serve as integrated complexes for medical, educational, and research facilities, thereby creating substantial expansion avenues for major hospital groups such as Max Healthcare Institute, Narayana Hrudayalaya, Apollo Hospital Enterprises, and Aster DM Healthcare. The budget also proposed establishing a new institution for allied healthcare professionals (AHPs) and training 1.5 lakh caregivers, addressing critical skill shortages within the industry.

Divergent Market Performance

On February 1, 2026, the market experienced a sharp correction, with the Nifty 50 and Sensex declining by 2.33 percent and 2.23 percent, respectively, following the Union Budget's proposal to hike the securities transaction tax (STT) on futures and options. In this challenging environment, Max Healthcare Institute shares closed 1.82 percent higher, reaching an intraday high of ₹996.40. Aster DM Healthcare followed suit, ending the day up 3.04 percent with an intraday peak of ₹573. Narayana Hrudayalaya also recorded gains, closing 1.82 percent higher after touching an intraday high of ₹1,821.20. Conversely, Apollo Hospital Enterprises, despite an intraday rise to ₹7,062, could not sustain its momentum and settled 1.03 percent lower.

Valuation and Sector Dynamics

Max Healthcare Institute, India's largest hospital chain by market capitalization, stood at approximately ₹93,121 crore as of January 31, 2026, with a P/E ratio around 66.07. The company has indicated plans to invest ₹1,000 crore in a new super-speciality hospital in Pune. Narayana Hrudayalaya, valued at about ₹36,128 crore with a P/E ratio nearing 42.73, has seen its valuation shift to an 'expensive' grade, though it continues to demonstrate strong long-term outperformance against the Sensex. Aster DM Healthcare, with a market cap around ₹28,668 crore and a P/E ratio of approximately 78.59, is undergoing a significant merger with Blackstone-backed Quality Care to create a larger hospital entity. Apollo Hospitals Enterprises, the largest by market cap at over ₹100,000 crore, showed mixed performance on the day. The broader Indian healthcare industry is projected for robust growth, with forecasts suggesting a market size of ₹54,67,022 crore (US$ 638 billion) by 2025, reflecting increasing healthcare expenditure as a percentage of GDP.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.